Imagia’s mission is to detect and quantify cancer changes early. When it matters. Despite systematic imaging and new genetic testing, tumor changes are often detected too late to improve cancer patient outcomes. Our Artificial Clinical Intelligence Platform enables us to provide critical information and timely imaging insights for primary tumors and metastasis for each cancer patient thus personalizing their cancer care continuum. Deep Radiomics™ — uniting radiomics and deep learning — utilizes existing routine clinical imaging data to discover robust imaging biomarkers that predict cancer patient outcomes.

Imagia’s mission is to detect and quantify cancer changes early. When it matters. Despite systematic imaging and new genetic testing, tumor changes are often detected too late to improve cancer patient outcomes. Our Artificial Clinical Intelligence Platform enables us to provide critical information and timely imaging insights for primary tumors and metastasis for each cancer patient thus personalizing their cancer care continuum. Deep Radiomics™ — uniting radiomics and deep learning — utilizes existing routine clinical imaging data to discover robust imaging biomarkers that predict cancer patient outcomes.

Aidence provides radiologists with a software platform that automatically detects and classifies various disorders on multiple imaging modalities. We are using Deep Learning, a revolutionary form of Artificial Intelligence, to teach computers to read medical images and automatically provide structured reports.

Aidence provides radiologists with a software platform that automatically detects and classifies various disorders on multiple imaging modalities. We are using Deep Learning, a revolutionary form of Artificial Intelligence, to teach computers to read medical images and automatically provide structured reports.